JANUVIA 25MG CPR C28 IRBESARTAN 150.00 MG Dupilumab 300 mg/2 mL

Description

Dupilumab 300 mg/2 mL

Concentración total: 0

PRESENTACIÓN: 1 SOBRES

Principio activo: Ketoconazol

Monitoreo de función inmunológica y posibles reacciones durante el tratamiento

JANUVIA 25MG CPR C28 IRBESARTAN 150.00 MG Dupilumab 300 mg/2 mLJANUVIA 25MG CPR C28

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy